| Structure | Chemical Name | CAS | MF |
|
NDP-4-keto-6-deoxy-D-glucose 3',5'-epimerase
|
|
|
|
|
NDP-4-keto-rhamnose 4'-ketoreductase
|
|
|
|
N-DOTRIACONTANE-D66
|
62369-68-0
|
C32D66
|
|
n-Dotriacontane
|
544-85-4
|
C32H66
|
|
negamycin
|
33404-78-3
|
C9H20N4O4
|
|
|
Negative Controls (Specify Test) ( FOR USE WITH LATEX REAGENTS)
|
|
|
|
|
Negative PS Printing Plate (YN-1)
|
|
|
|
|
NEGATIVE CONTROL (EPOS)
|
|
|
|
|
Negative Febrile Control
|
|
|
|
|
Negative Control
|
|
|
|
|
Negative Stain w/Virus Particle Count - w/ 4-6 photos
|
|
|
|
|
Negative control serum
|
|
|
|
|
negative elongation factor
|
|
|
|
|
nefloxacin
|
146239-82-9
|
|
|
N-(4-{[2-({[(E)-3-(4-fluorophenyl)-2-propenoyl]amino}carbothioyl)hydrazino]carbonyl}phenyl)cyclopropanecarboxamide
|
|
C21H19FN4O3S
|
|
N-[(E)-(4-fluorophenyl)methylidene]-N-(5-{[(E)-(4-fluorophenyl)methylidene]amino}-1-naphthyl)amine
|
|
C24H16F2N2
|
|
N-[(E)-(4-fluorophenyl)methylidene]-N-[4-(4-{[(E)-(4-fluorophenyl)methylidene]amino}benzyl)phenyl]amine
|
|
C27H20F2N2
|
|
N'-[(E)-3-(4-fluorophenyl)-2-propenoyl]cyclopropanecarbohydrazide
|
|
C13H13FN2O2
|
|
N-[(E)-(4-fluorophenyl)methylidene]-N-(4'-{[(E)-(4-fluorophenyl)methylidene]amino}-3,3'-dimethyl[1,1'-biphenyl]-4-yl)amine
|
|
C28H22F2N2
|
|
N'-[(E)-(4-FLUOROPHENYL)METHYLIDENE]BENZENESULFONOHYDRAZIDE
|
118795-05-4
|
C13H11FN2O2S
|
|
N'-[(1E)-(4-FLUOROPHENYL)METHYLENE]-2-[5-PHENYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]-1,3-THIAZOLE-4-CARBOHYDRAZIDE
|
|
C21H13F4N5OS
|
|
N'-[(1E)-(4-FLUOROPHENYL)METHYLENE]-2-[3-PHENYL-5-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]-1,3-THIAZOLE-4-CARBOHYDRAZIDE
|
|
C21H13F4N5OS
|
|
N-[(E)-2-(2-FLUOROPHENYL)-1-({[3-(1H-IMIDAZOL-1-YL)PROPYL]AMINO}CARBONYL)ETHENYL]-3,4-DIMETHOXYBENZAMIDE
|
|
C24H25FN4O4
|
|
N'-((E)-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]METHYLIDENE)-2-METHYL-2-(1H-1,2,4-TRIAZOL-1-YL)PROPANOHYDRAZIDE
|
477711-43-6
|
C16H16FN7O
|
|
N'-((E)-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]METHYLIDENE)-2,5-BIS(2,2,2-TRIFLUOROETHOXY)BENZENECARBOHYDRAZIDE
|
477711-42-5
|
C21H15F7N4O3
|
|
N'-[(E)-(4-FLUOROPHENYL)METHYLIDENE]-2-[3-METHYL-5-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]-1,3-THIAZOLE-4-CARBOHYDRAZIDE
|
956266-40-3
|
C16H11F4N5OS
|
|
N-{4-[({4-[(E)-2-(2-FLUOROPHENYL)VINYL]PYRIMIDIN-2-YL}AMINO)SULFONYL]PHENYL}ACETAMIDE
|
|
C20H17FN4O3S
|
|
N'-[(E)-(4-fluorophenyl)methylidene]-2-[3-methyl-5-(trifluoromethyl)-1H-pyrazol-1-yl]-1,3-thiazole-4-carbohydrazide
|
|
C16H11F4N5OS
|
|
N'-{(E)-[2-(4-fluorophenyl)-5,6,7,8-tetrahydroimidazo[2,1-b][1,3]benzothiazol-3-yl]methylidene}-2-thiophenecarbohydrazide
|
|
C21H17FN4OS2
|
|
N-[(2E)-3-[2-(6-FLUORO-1H-INDOL-3-YL)ETHYL]-4-(4-METHOXYPHENYL)-1,3-THIAZOL-2(3H)-YLIDENE]-N-PHENYLAMINE
|
|
C26H22FN3OS
|
|
N'-((E)-[4-(3-FLUOROPROPOXY)PHENYL]METHYLIDENE)-2,5-BIS(2,2,2-TRIFLUOROETHOXY)BENZENECARBOHYDRAZIDE
|
477870-68-1
|
C21H19F7N2O4
|
|
N'-[(1E)-(2-FLUOROPHENYL)METHYLENE]-5-NITRO-1H-IMIDAZOLE-4-CARBOHYDRAZIDE
|
|
C11H8FN5O3
|
|
N'-[(1E)-1-(4-FLUOROPHENYL)ETHYLIDENE]-5-NITRO-1H-IMIDAZOLE-4-CARBOHYDRAZIDE
|
|
C12H10FN5O3
|
|
N'-((E)-[2-(4-FLUOROPHENOXY)PHENYL]METHYLIDENE)-4-(TRIFLUOROMETHYL)BENZENECARBOHYDRAZIDE
|
338393-78-5
|
C21H14F4N2O2
|
|
N-[(2E)-3-[2-(6-FLUORO-1H-INDOL-3-YL)ETHYL]-4-PHENYL-1,3-THIAZOL-2(3H)-YLIDENE]-N-PHENYLAMINE
|
|
C25H20FN3S
|
|
N-[(E)-(2-fluorophenyl)methylidene]-2,2,4-trimethyl-2,3-dihydro-1-benzofuran-7-amine
|
|
C18H18FNO
|
|
N'-{(E)-[3-(4-fluorophenyl)-1H-pyrazol-4-yl]methylidene}-2,5-bis(2,2,2-trifluoroethoxy)benzenecarbohydrazide
|
|
C21H15F7N4O3
|
|
N-[(E)-(4-fluorophenyl)methylidene]-2,2,4-trimethyl-2,3-dihydro-1-benzofuran-7-amine
|
|
C18H18FNO
|
|
N'-((E)-{4-[(4-fluorobenzyl)oxy]phenyl}methylidene)-2-thiophenecarbohydrazide
|
|
C19H15FN2O2S
|
|
N-[(E)-(2-fluorophenyl)methylidene]-5-isoquinolinamine
|
|
C16H11FN2
|
|
N'-{(E)-[3-(4-fluorophenyl)-1H-pyrazol-4-yl]methylidene}-2-methyl-2-(1H-1,2,4-triazol-1-yl)propanohydrazide
|
|
C16H16FN7O
|
|
N'-((E)-{4-[(4-fluorobenzyl)oxy]phenyl}methylidene)-2-phenylacetohydrazide
|
|
C22H19FN2O2
|
|
N'-((E)-[4-(3-FLUOROPROPOXY)PHENYL]METHYLIDENE)-4-(TRIFLUOROMETHYL)BENZENECARBOHYDRAZIDE
|
477889-02-4
|
C18H16F4N2O2
|
|
N'-((E)-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]METHYLIDENE)-1-METHYL-1H-PYRROLE-2-CARBOHYDRAZIDE
|
477711-41-4
|
C16H14FN5O
|
|
Neflumozide
|
86636-93-3
|
C22H23FN4O2
|
|
N'-[(1E)-(2-FLUOROPHENYL)METHYLENE]-5-METHYL-1,2,3-THIADIAZOLE-4-CARBOHYDRAZIDE
|
|
C11H9FN4OS
|
|
N'-[(E)-(4-FLUOROPHENYL)METHYLIDENE]-1-[(4-METHYLPHENYL)SULFONYL]-4-PIPERIDINECARBOHYDRAZIDE
|
324531-41-1
|
C20H22FN3O3S
|
|
N'-[(E)-(2-FLUOROPHENYL)METHYLIDENE]BENZENESULFONOHYDRAZIDE
|
355831-71-9
|
C13H11FN2O2S
|
|
N-[(E)-(4-fluorophenyl)methylidene]-N-{4-[9-(4-{[(E)-(4-fluorophenyl)methylidene]amino}phenyl)-9H-fluoren-9-yl]phenyl}amine
|
|
C39H26F2N2
|
|
N-[4-({2-[(E)-(4-fluorophenyl)methylidene]hydrazino}carbonyl)phenyl]-3-methylbenzamide
|
|
C22H18FN3O2
|
|
N-[(E)-3-(4-fluorophenyl)-2-propenoyl]-N'-(2-methoxyphenyl)thiourea
|
|
C17H15FN2O2S
|
|
N-[(E)-3-(4-fluorophenyl)-2-propenoyl]-N'-isopropylthiourea
|
|
C13H15FN2OS
|
|
N-[(E)-3-(4-fluorophenyl)-2-propenoyl]-N'-[4-(4-morpholinylsulfonyl)phenyl]thiourea
|
|
C20H20FN3O4S2
|
|
N-(4-{[2-({[(E)-3-(4-fluorophenyl)-2-propenoyl]amino}carbothioyl)hydrazino]carbonyl}phenyl)benzamide
|
|
C24H19FN4O3S
|
|
N-[(E)-3-(4-fluorophenyl)-2-propenoyl]-N'-{4-[(4-methyl-1-piperazinyl)sulfonyl]phenyl}thiourea
|
|
C21H23FN4O3S2
|
|
N-[4-({2-[(E)-3-(4-fluorophenyl)-2-propenoyl]hydrazino}carbonyl)phenyl]cyclohexanecarboxamide
|
|
C23H24FN3O3
|
|
N'-[(E)-3-(4-fluorophenyl)-2-propenoyl]-2-(2-methylphenoxy)acetohydrazide
|
|
C18H17FN2O3
|
|
N-[4-({2-[(E)-(4-fluorophenyl)methylidene]hydrazino}carbonyl)phenyl]cyclopropanecarboxamide
|
|
C18H16FN3O2
|
|
N-(4-{[2-({[(E)-3-(4-fluorophenyl)-2-propenoyl]amino}carbothioyl)hydrazino]carbonyl}phenyl)-2-methylbenzamide
|
|
C25H21FN4O3S
|
|
N-(4-{[2-({[(E)-3-(4-fluorophenyl)-2-propenoyl]amino}carbothioyl)hydrazino]carbonyl}phenyl)-3-methylbenzamide
|
|
C25H21FN4O3S
|
|
|
NEF MN (162-176) (1) (3)
|
|
|
|
|
NEF MN (64-75) (3)
|
|
|
|
|
NEF MN (95-108) (3)
|
|
|
|
|
NEF MN (48-62) (1)
|
|
|
|
|
NEF MN (53-64) (1)
|
|
|
|
|
NEF MN (171-182) (1)
|
|
|
|
|
NEF MN (56-69) (1)
|
|
|
|
|
NEF MN (134-149) (1)
|
|
|
|
NEF MN (115-127)
|
|
C85H103N19O21
|
|
NEF MN (123-137)
|
|
C86H115N21O23
|
|
NEF MN (48-62)
|
|
C63H96N18O25S
|
|
NEF MN (171-182)
|
|
C62H99N23O18S2
|
|
NEF MN (53-64)
|
|
C56H83N15O22S
|
|
|
NEF MN (157-170) (1) (3)
|
|
|
|
NEF MN (76-87)
|
|
C63H106N16O15S
|
|
NEF MN (68-82)
|
|
C78H128N20O18S
|
|
NEF MN (145-157)
|
|
C73H117N15O22
|
|
NEF MN (150-161)
|
|
C57H95N15O22
|
|
|
N-(4-doxorubicin-N-carbonyl(oxymethyl)phenyl)-O-glucuronyl carbamate
|
|
|
|
|
N-doxylstearoylgalactosylsphingosine I(3) sulfate
|
|
|
|
|
16-n-Doxylstearic acid
|
|
|
|
|
5-n-Doxylstearic acid
|
|
|
|
NefopaM N-Oxide
|
66091-32-5
|
C17H19NO2
|
|
NefopaM-d3 Hydrochloride
|
1346747-15-6
|
C17H20ClNO
|
|
NefopaM-d3 N-Oxide
|
|
C17H19NO2
|
|
|
NefopaM-D4
|
|
|
|
Nefopam hydrochloride
|
23327-57-3
|
C17H20ClNO
|
|
3-Methyl-7-phenyl-6-oxa-3-azabicyclo[6.4.0]dodeca-8,10,12-triene
|
13669-70-0
|
C17H19NO
|
|
N-[4-[(E)-2-[(2E,5Z)-2,5-Octadienylidene]-5-oxopyrrolidin-1-yl]butyl]guanidine
|
84453-27-0
|
|
|
|
NDP protein
|
|
|
|
|
NEF protein, SIV
|
|
|
|
|
Nef receptor
|
|
|
|
|
Nefrine perchlorate
|
|
|
|
|
ND1 protein
|
|
|
|
|
ND9 protein
|
|
|
|
|
Nd1 protein, mouse
|
|
|
|
|
ND3 protein
|
|
|
|
|
ND7 protein
|
|
|
|
|
nd1 protein, R. capsulatus
|
|
|
|
|
Negishi virus envelope glycoprotein
|
134088-85-0
|
|